Cargando…

Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction

BACKGROUND: In patients with refractory heart failure (HF) peritoneal dialysis (PD) is associated with improved functional status and decrease in hospitalization. However, previous studies did not focus on right ventricular dysfunction as an important pathophysiologic component of cardiorenal syndro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavo, Noemi, Yarragudi, Rajashri, Puttinger, Heidi, Arfsten, Henrike, Strunk, Guido, Bojic, Andja, Hülsmann, Martin, Vychytil, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242305/ https://www.ncbi.nlm.nih.gov/pubmed/30452453 http://dx.doi.org/10.1371/journal.pone.0206830

Ejemplares similares

Chronic Peritoneal Drainage in Refractory Right Heart Failure and Ascites
por: Yarragudi, Rajashri, et al.
Publicado: (2022)

New‐Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis—A Review
por: Yarragudi, Rajashri, et al.
Publicado: (2019)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020)

Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?
por: Pavo, Noemi, et al.
Publicado: (2022)

Malnutrition outweighs the effect of the obesity paradox
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
por: Arfsten, Henrike, et al.
Publicado: (2021)

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Increased concentrations of bioactive adrenomedullin subsequently to angiotensin‐receptor/neprilysin‐inhibitor treatment in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2020)

Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data
por: Frey, Maria Klara, et al.
Publicado: (2021)

The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
por: Pavo, Noemi, et al.
Publicado: (2019)

Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis
por: Kunin, Margarita, et al.
Publicado: (2015)

Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2019)

Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
por: Prausmüller, Suriya, et al.
Publicado: (2022)

GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
por: Arfsten, Henrike, et al.
Publicado: (2019)

Relevance of Neutrophil Neprilysin in Heart Failure
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study
por: Bartko, Philipp E, et al.
Publicado: (2021)

Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure
por: Pavo, Noemi, et al.
Publicado: (2019)

Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure
por: Kunin, Margarita, et al.
Publicado: (2019)

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic
por: Han, Emilie, et al.
Publicado: (2023)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
por: Arfsten, Henrike, et al.
Publicado: (2021)

Efficacy of peritoneal dialysis in patients with refractory congestive heart failure: a systematic review and meta-analysis
por: Timóteo, Ana Teresa, et al.
Publicado: (2023)

Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome
por: Shao, Qiuyuan, et al.
Publicado: (2018)

Peritoneal and Urinary Sodium Removal in Refractory Congestive Heart Failure Patients Included in an Ambulatory Peritoneal Dialysis Program: Valuable for Monitoring the Course of the Disease
por: Miñana, Gema, et al.
Publicado: (2023)

The role of peritoneal ultrafiltration in the treatment of refractory congestive heart failure
por: Samoni, Sara, et al.
Publicado: (2015)

Ultrafiltration by Peritoneal Route in Refractory Chronic Congestive Cardiac Failure
por: Hedau, S., et al.
Publicado: (2018)

An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid Regurgitation
por: Spinka, Georg, et al.
Publicado: (2020)

Secondary mitral regurgitation—Insights from microRNA assessment
por: Spinka, Georg, et al.
Publicado: (2020)

Relapsing and refractory peritoneal dialysis peritonitis caused by Corynebacterium amycolatum
por: Habeeb, Shameer M., et al.
Publicado: (2022)

Vibrational Spectroscopy of Peritoneal Dialysis Effluent for Rapid Assessment of Patient Characteristics
por: Grunert, Tom, et al.
Publicado: (2020)

Mesenteric ischemia masquerading as refractory peritonitis in continuous ambulatory peritoneal dialysis patients
por: Vishwakarma, K., et al.
Publicado: (2015)

Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure
por: Kihm, Lars P., et al.
Publicado: (2011)

Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis
por: Kerschbaum, Julia, et al.
Publicado: (2013)

Surgical Intervention after Catheter Removal in a Case of Refractory Peritoneal Dialysis-Related Peritonitis
por: Yan, Hao, et al.
Publicado: (2015)

Refractory Peritoneal Dialysis Peritonitis Due to Neisseria macacae: A Case Report and Review of the Literature
por: Iyama, Takuji, et al.
Publicado: (2020)

Matrix Metalloproteinase-7 Associated with Congestive Heart Failure in Peritoneal Dialysis Patients: A Prospective Cohort Study
por: Xiao, Zhiwen, et al.
Publicado: (2023)

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload
por: Johnson, David Wayne, et al.
Publicado: (2001)

Peritoneal dialysis for the rescue in critical refractory metabolic acidosis in diabetic ketoacidosis
por: Singh, Harpreet, et al.
Publicado: (2019)

Refractory Hypotension Caused by Selenium Deficiency in a Patient on Peritoneal Dialysis
por: Ryuge, Akihiro, et al.
Publicado: (2021)

The curious right-sided predominance of peritoneal dialysis-related hydrothorax
por: Guest, Steven
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_udvdmuqsm42tstd0s24c5fjiel